Attenua, Inc.   Report issue

For profit Phase 2
Founded: Mountain View CA United States (2015)
Status: Acquired by Coda Biotherapeutics (2020)

Organization Overview

First Clinical Trial
2018
NCT03622216
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Attenua, Inc.